Intramedullary Fixation of Pathological Fractures and Lesions of the Subtrochanteric Region of the Femur
Overview
Orthopedics
Authors
Affiliations
The Zickel intramedullary appliance was used without methylmethacrylate in forty-six patients to stabilize thirty-five fractures and eleven impending fractures associated with osseous lesions in the subtrochanteric region of the femur. Early mobilization or ambulation was possible in nearly all cases. The patients with actual fractures survived an average of 4.7 months, while those with lesions stabilized prophylactically survived an average of 13.8 months postoperatively. Fourteen of the thirty-five patients with fractures showed union after an average of 4.5 months.
DiCaprio M, Murtaza H, Palmer B, Evangelist M Ann Jt. 2024; 7:28.
PMID: 38529136 PMC: 10929274. DOI: 10.21037/aoj-20-97.
Philipp T, Mikula J, Doung Y, Gundle K Clin Orthop Relat Res. 2020; 478(3):540-546.
PMID: 32168065 PMC: 7145091. DOI: 10.1097/CORR.0000000000000803.
Fracture risk assessment and clinical decision making for patients with metastatic bone disease.
Damron T, Mann K J Orthop Res. 2020; 38(6):1175-1190.
PMID: 32162711 PMC: 7225068. DOI: 10.1002/jor.24660.
Surgical management of metastatic lesions of proximal femur and the hip.
Khattak M, Ashraf U, Nawaz Z, Noordin S, Umer M Ann Med Surg (Lond). 2018; 36:90-95.
PMID: 30450202 PMC: 6226618. DOI: 10.1016/j.amsu.2018.09.042.
Tatar Z, Soubrier M, Dillies A, Verrelle P, Boisgard S, Lapeyre M Radiat Oncol. 2014; 9:227.
PMID: 25319635 PMC: 4205287. DOI: 10.1186/s13014-014-0227-1.